Distinct impaired regulation of SOCS3 and long and short isoforms of the leptin receptor in visceral and subcutaneous fat of lean and obese women

Biochemical and Biophysical Research Communications

Volumn 348, Issue 4, 2006, Pages 1232-1238

  Séron, Karin ^a   Corset, Laetitia ^a   Vasseur, Francis ^b   Boutin, Philippe ^a   Gómez Ambrosi, Javier ^c   Salvador, Javier ^c   Frühbeck, Gema ^c   Froguel, Philippe ^a,d  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Adipose tissue; Human; Leptin receptors; Obesity; Real time PCR; SOCS3

Indexed keywords

ISOPROTEIN; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTUM; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT;

ANIMALIA;

EID: 33747876123     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.068     Document Type: Article

References (48)

1. Ahima R.S., and Flier J.S. Leptin. Annu. Rev. Physiol. 62 (2000) 413-437
2. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., and Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
3. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
4. Bjorbaek C., and Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res. 59 (2004) 305-331
5. Bennett F.I., McFarlane-Anderson N., Wilks R., Luke A., Cooper R.S., and Forrester T.E. Leptin concentration in women is influenced by regional distribution of adipose tissue. Am. J. Clin. Nutr. 66 (1997) 1340-1344
6. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
7. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21 (2000) 697-738
8. Montague C.T., Prins J.B., Sanders L., Digby J.E., and O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46 (1997) 342-347
9. Arner P. Not all fat is alike. Lancet 351 (1998) 1301-1302
10. Tartaglia L.A. The leptin receptor. J. Biol. Chem. 272 (1997) 6093-6096
11. Bailleul B., Akerblom I., and Strosberg A.D. The leptin receptor promoter controls expression of a second distinct protein. Nucleic Acids Res. 25 (1997) 2752-2758
12. Cioffi J.A., Shafer A.W., Zupancic T.J., Smith-Gbur J., Mikhail A., Platika D., and Snodgrass H.R. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat. Med. 2 (1996) 585-589
13. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
14. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem. J. 393 (2006) 7-20
15. Bjorbaek C., El-Haschimi K., Frantz J.D., and Flier J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274 (1999) 30059-30065
16. Bjorbaek C., Lavery H.J., Bates S.H., Olson R.K., Davis S.M., Flier J.S., and Myers Jr. M.G. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275 (2000) 40649-40657
17. Munzberg H., and Myers Jr. M.G. Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 8 (2005) 566-570
18. Huan J.N., Li J., Han Y., Chen K., Wu N., and Zhao A.Z. Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance. J. Biol. Chem. 278 (2003) 45638-45650
19. Wang M.Y., Orci L., Ravazzola M., and Unger R.H. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc. Natl. Acad. Sci. USA 102 (2005) 18011-18016
20. Rieusset J., Bouzakri K., Chevillotte E., Ricard N., Jacquet D., Bastard J.P., Laville M., and Vidal H. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53 (2004) 2232-2241
21. World Health Organization Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO/NUT/NCD/981, WHO, Geneva (1998).
22. Expert Panel, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. Bethesda, MD: National Institute of Health, National Heart, Lung, and Blood Institute, U. S. Department of Health and Human Services, Public Health Service (1998).
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the Diagnosis of Diabetes Mellitus, Diabetes Care 26 (2003) 3160-3167.
24. Sardinha L.B., Lohman T.G., Teixeira P.J., Guedes D.P., and Going S.B. Comparison of air displacement plethysmography with dual-energy X-ray absorptiometry and 3 field methods for estimating body composition in middle-aged men. Am. J. Clin. Nutr. 68 (1998) 786-793
25. Elia M., and Ward L.C. New techniques in nutritional assessment: body composition methods. Proc. Nutr. Soc. 58 (1999) 33-38
26. Wells J.C., and Fuller N.J. Precision of measurement and body size in whole-body air-displacement plethysmography. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1161-1167
27. Fields D.A., Higgins P.B., and Radley D. Air-displacement plethysmography: here to stay. Curr. Opin. Clin. Nutr. Metab. Care 8 (2005) 624-629
28. Ginde S.R., Geliebter A., Rubiano F., Silva A.M., Wang J., Heshka S., and Heymsfield S.B. Air displacement plethysmography: validation in overweight and obese subjects. Obes. Res. 13 (2005) 1232-1237
29. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22 (1969) 158-161
30. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
31. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21 (1998) 2191-2192
32. Lonnqvist F., Arner P., Nordfors L., and Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med. 1 (1995) 950-953
33. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Bauer T.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334 (1996) 292-295
34. Franks P.W., Brage S., Luan J., Ekelund U., Rahman M., Farooqi I.S., Halsall I., O'Rahilly S., and Wareham N.J. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes. Res. 13 (2005) 1476-1484
35. Kutoh E., Boss O., Levasseur F., and Giacobino J.P. Quantification of the full length leptin receptor (OB-Rb) in human brown and white adipose tissue. Life Sci. 62 (1998) 445-451
36. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., Hotamisligil G.S., and Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem. 276 (2001) 47944-47949
37. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., and Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1 (1998) 619-625
38. Linder K., Arner P., Flores-Morales A., Tollet-Egnell P., and Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J. Lipid Res. 45 (2004) 148-154
39. Wang Z.W., Pan W.T., Lee Y., Kakuma T., Zhou Y.T., and Unger R.H. The role of leptin resistance in the lipid abnormalities of aging. FASEB J. 15 (2001) 108-114
40. Barr V.A., Lane K., and Taylor S.I. Subcellular localization and internalization of the four human leptin receptor isoforms. J. Biol. Chem. 274 (1999) 21416-21424
41. Uotani S., Bjorbaek C., Tornoe J., and Flier J.S. Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes 48 (1999) 279-286
42. Bjorbaek C., Uotani S., da Silva B., and Flier J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 272 (1997) 32686-32695
43. Kellerer M., Koch M., Metzinger E., Mushack J., Capp E., and Haring H.U. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40 (1997) 1358-1362
44. Zhao A.Z., Shinohara M.M., Huang D., Shimizu M., Eldar-Finkelman H., Krebs E.G., Beavo J.A., and Bornfeldt K.E. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J. Biol. Chem. 275 (2000) 11348-11354
45. Vaisse C., Halaas J.L., Horvath C.M., Darnell Jr. J.E., Stoffel M., and Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14 (1996) 95-97
46. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., and Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93 (1996) 6231-6235
47. Huang K.C., Chuang L.M., Chen C.Y., Chow S.N., and Lin R.S. Serum leptin and leptin receptor isoforms in omental adipose tissue of nondiabetic women undergoing gynecologic surgery for benign disease. J. Formos. Med. Assoc. 99 (2000) 839-843
48. Good D.J. How tight are your genes? Transcriptional and posttranscriptional regulation of the leptin receptor, NPY, and POMC genes. Horm. Behav. 37 (2000) 284-298